FMC, DE0005785802

6008 CAREsystem from Fresenius Medical Care AG - quieter dialysis and workflow focus

Veröffentlicht: 29.06.2026 um 21:26 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

The 6008 CAREsystem raises the bar for in-centre hemodialysis with integrated fluid management and a streamlined user interface for nurses and technicians. This bestseller drives the price of Fresenius Medical Care AG shares (ISIN DE0005785802).

FMC, DE0005785802, Illustration mit AI erstellt.
FMC, DE0005785802, Illustration mit AI erstellt.

Reviewed: ad hoc news Bestseller & Flagship desk. Edited and checked on 2026-06-29, 21:25. Details in the imprint.

The 6008 CAREsystem from Fresenius Medical Care AG sits in the dialysis room with a quiet hum, screen glowing soft blue while a nurse glides a gloved finger over the touchscreen. Tubing is tidy, connectors click with a firm, tactile feel that reassures both staff and patients.

What the 6008 machine does

The 6008 CAREsystem is Fresenius Medical Care's latest generation in-centre hemodialysis platform, designed to deliver high-volume therapy with consistent quality in routine care. According to the manufacturer, it automates key steps such as priming, rinsing and disinfection to free up nursing time.Official 6008 CAREsystem product page

Dr. Carla Kriwet, CEO of Fresenius Medical Care, has highlighted the 6008 platform as central to the group's strategy of making dialysis workflows more efficient while keeping clinical standards high. The system integrates therapy data collection, enabling clinics to track patient treatments without manual data transfer.Fresenius Medical Care press releases

How it feels in daily use

On the front of the 6008 CAREsystem, the tilt-adjustable colour display meets the operator at eye level, reducing neck strain during long shifts. Buttons are large and clearly labeled, and the machine gives a clean acoustic signal rather than a shrill alarm when routine prompts appear, easing stress in busy rooms.English-language 6008 CAREsystem page

Dialysis nurse Anna Müller from a mid-sized German clinic describes the new-generation unit as more tidy around the cartridge area than older models, with fewer exposed tubes to snag on clothing. Handling the disposable components feels smoother, thanks to clearly guided insertion points and a more robust housing.

Go deeper

Background on Fresenius Medical Care AG shares

The 6008 CAREsystem sits at the core of Fresenius Medical Care AG's dialysis offering, which many investors follow via the MDAX listing of the company.

What the 6008 changes in practice

The 6008 CAREsystem is designed to work with Fresenius Medical Care's disposable cassette concept, which pre-configures fluid pathways in a sealed cartridge. This reduces the number of individual connections staff must make and lowers the contamination risk compared with open-line setups.

Compared with its predecessor models in the 5000-series, the 6008 adds integrated balancing chambers and more precise control of ultrafiltration volume. Clinics can program patient-specific fluid removal profiles, supporting more consistent therapy especially for long-term patients with narrow tolerance windows.

Strengths and trade-offs

One convincing strength is the focus on automating recurring tasks: self-filling of the dialyser, automatic saline loading and standardized disinfection cycles. These features help clinics with limited staffing keep chairs turning without cutting corners on hygiene processes.

The trade-off is complexity in the initial setup phase and staff training. Dialysis technicians must learn the system's menu structure and cassette handling routines, which can feel raw at first for teams used to simple knob-based machines, especially in smaller centres.

Pricing and availability

Fresenius Medical Care positions the 6008 CAREsystem as a premium in-centre solution, typically sold to clinics and hospitals in Europe and other regions via tender processes. The company does not publish a public list price, as contracts often bundle machines, disposables and service packages.

In Germany, the 6008 CAREsystem is marketed to nephrology centres and hospital dialysis units rather than directly to individual consumers. Ordering usually runs through Fresenius Medical Care's local sales organizations, which configure installations to match the number of stations and water treatment systems.

Company context and shares

Fresenius Medical Care AG is one of the world's largest providers of dialysis products and services, with treatment centres and equipment installations across Europe, the Americas and Asia. The 6008 CAREsystem underpins its equipment offering in many of these markets as clinics upgrade older fleets.

Fresenius Medical Care AG shares (ISIN DE0005785802) trade on Xetra under the ticker FME, with recent prices around the low-40-euro range according to exchange data from late June 2026.

Key facts on the 6008 CAREsystem

  • Product: 6008 CAREsystem
  • Manufacturer: Fresenius Medical Care AG & Co. KGaA
  • Category: Flagship in-centre hemodialysis system
  • Launch: Gradual rollout from mid-2010s, now broadly available
  • RRP / Price: Contract-based clinic pricing, not publicly listed
  • Availability: Dialysis centres and hospitals via Fresenius Medical Care sales channels, including Germany and wider Europe
  • Target group: Professional dialysis providers treating chronic kidney disease patients
  • Highlight / USP: Integrated cassette system and automated workflows for efficient, high-quality hemodialysis

Find the 6008 CAREsystem in media

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | DE0005785802 | FMC | boerse | 69655282 | bgmi